How are you liking our new look? Tell us what you think, good or bad we want to hear it.

FDA panel recommends Pfizer’s low-dose Covid vaccine for kids ages 5 to 11

3 months ago·Washington, United States
Articles
G
General Summary
A key Food and Drug Administration advisory committee on Tuesday recommended a lower dose of Pfizer and BioNTech’s Covid-19 vaccine for children ages 5 to 11, a critical step in getting some 28 million more kids in the U.S. protected against the virus as the delta variant spreads.
Summary by Ground News
Yahoo News

FDA advisers back Pfizer’s COVID-19 vaccine for young kids

A panel of U.S. health advisers on Tuesday endorsed kid-size doses of Pfizer's COVID-19 vaccine, moving the U.S. closer to beginning vaccinations in children ages 5 to 11. A Food and Drug Administration advisory panel voted unanimously with one abstention that the vaccine's benefits in preventing COVID-19 in that age group outweigh any potential risks — including a heart-related side effect that's been very rare in teens and young adults who get…

3 months ago·Los Angeles, United States
Ownership:Verizon Communications
CBC News

FDA advisory committee recommends authorizing Pfizer's COVID vaccine for kids

The U.S. Food and Drug Administration isn't bound by the committee's recommendation, but is expected to consider it and make a decision in the coming days on whether to approve the vaccine for kids five to 11 years old.

3 months ago·Canada
Ownership:Canadian Broadcasting Corporation
Reuters

U.S. FDA advisers back Pfizer/BioNTech COVID-19 vaccine for children

An expert panel on Tuesday voted overwhelmingly to recommend the U.S. Food and Drug Administration authorize the Pfizer Inc and BioNTech SE COVID-19 vaccine for children ages 5 to 11, saying the benefits of inoculation outweigh the risks.

3 months ago·United Kingdom
Ownership:The Woodbridge Company
News18 India

U.S. FDA Advisers Back Pfizer/BioNTech COVID-19 Vaccine For Children

An expert panel on Tuesday voted overwhelmingly to recommend the U.S. Food and Drug Administration authorize the Pfizer Inc and BioNTech SE COVID19 vaccine for children ages 5 to 11, saying the benefits of inoculation outweigh the risks.

3 months ago·India
Ownership:Dhirubhai Ambani
CTV News

U.S. FDA advisers back Pfizer's COVID-19 vaccine for young kids

The U.S. moved a step closer to expanding COVID-19 vaccinations for millions more children as government advisers on Tuesday endorsed kid-size doses of Pfizer's shots for 5- to 11-year-olds.

3 months ago·Toronto, Canada
Ownership:BCE Inc.
The Hindu

U.S. FDA panel backs Pfizer’s low-dose COVID-19 vaccine for children

A Food and Drug Administration advisory panel voted unanimously, that the vaccine’s benefits in preventing COVID-19 in the 5-11 age group outweigh any potential risks.

3 months ago·India
Ownership:The Hindu Group

Bias Distribution

52% of the sources are Center
Common Dreams
CGTN
CBC News
The Hindu
NDTV
USA Today
The Independent
abc News
+26
Reuters
CTV News
CBS Local
NZ Herald
CNBC
Associated Press News
+63
News18 India
Washington Times
Independent.ie
The Telegraph
Financial Post
Russia Today
+16
Daily Express
Washington Examiner
The Daily Wire
National Review
Sky News Australia
CBN
+1
The Gateway Pundit
WND
L 25%
C 53%
R 22%
Untracked bias
Yahoo NewsTodayKIFIBloomberg QuintEcnsFijiTimesMedscape WLWTWDSUJamaica Observer
+34
0